Dannie Williams
Family Medicine · Overland, MONPI 1568626349
Payments from drug & device makers
Across 259 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$614
- Novo Nordisk$569
- Lilly USA, LLC$432
- AstraZeneca$355
- Takeda Pharmaceuticals U.S.A., Inc.$197
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,63599%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 78 | $1,142 |
| Otsuka America Pharmaceutical, Inc. | 26 | $614 |
| Novo Nordisk | 30 | $569 |
| Lilly USA, LLC | 21 | $432 |
| AstraZeneca | 22 | $355 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $197 |
| Pfizer | 18 | $179 |
| Biohaven Pharmaceuticals, Inc. | 3 | $168 |
| Nestle Healthcare Nutrition Inc. | 8 | $148 |
| Bayer | 1 | $145 |
| Astellas Pharma US Inc | 5 | $96 |
| Lundbeck LLC | 4 | $95 |
| Novartis | 4 | $85 |
| Merck | 5 | $79 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $78 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Sentynl Therapeutics, Inc. | 3 | $43 |
| Exact Sciences | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 2 | $27 |
| Upsher-smith Laboratories LLC | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Amgen | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$150
- Kerendia$145
- NURTEC ODT$125
How this compares
$4,682 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 114 | $137,423 |
| MounjaroTirzepatide | 96 | $106,469 |
| TrulicityDulaglutide | 84 | $93,811 |
| RexultiBrexpiprazole | 41 | $59,567 |
| JardianceEmpagliflozin | 52 | $55,583 |
| ZenpepLipase/Protease/Amylase | 37 | $53,605 |
| EliquisApixaban | 47 | $50,577 |
| LinzessLinaclotide | 45 | $43,791 |
| EntrestoSacubitril/Valsartan | 36 | $38,733 |
| RybelsusSemaglutide | 25 | $31,915 |
| VraylarCariprazine Hcl | 20 | $31,246 |
| OxycontinOxycodone Hcl | 35 | $28,818 |
| MyrbetriqMirabegron | 25 | $28,679 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $26,658 |
| Hysingla ErHydrocodone Bitartrate | 24 | $23,736 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $432 | $200,280180 claims |
| Novo NordiskOzempic, Rybelsus | $569 | $169,338139 claims |
| AbbVieLinzess, Vraylar, Ubrelvy | $1,142 | $95,08778 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $614 | $59,56741 claims |
| PfizerEliquis | $179 | $50,57747 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $355 | $48,465101 claims |
| NovartisEntresto | $85 | $38,73336 claims |
| Astellas Pharma US IncMyrbetriq | $96 | $28,67925 claims |
| MerckJanuvia, Janumet | $79 | $21,50130 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $197 | $16,89041 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $27 | $12,01414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Overland
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.